Human bioavailability study of benznidazole for treatment of Chagas disease, a neglected tropical disease.
Phase of Trial: Phase I
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Benznidazole (Primary)
- Indications Chagas disease
- Focus Pharmacokinetics
- Sponsors Humanigen
- 14 Aug 2017 New trial record
- 09 Aug 2017 According to Humanigen media release, company received clearance from the FDA in June 2017 for its Investigational New Drug (IND) application for benznidazole.
- 09 Aug 2017 According to Humanigen media release, analysis of the study has begun and anicipates its preliminary results by Oct 2017. Also, the final study report will expect in fourth quater of 2017.